Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals

Investigators at the Université de Montréal, published in mBio, has investigated the duration of antibodies against SARS-CoV-2 in people who were recovering from COVID-19. This has important implications for the use of plasma as a potential treatment for COVID-19.